Table 2.
Patient characteristics depending on the portal pressure gradient (PPG) at the time of transjugular intrahepatic portosystemic stent shunt (TIPSS)
| Group 1 (n=38) | Group 2 (n=254) | p Value | |
| Age (y) | 54.9 (1.9) | 52.5 (0.8) | NS |
| Sex | |||
| Male | 25 (65.8%) | 157 (61.8%) | NS |
| Female | 13 (34.2%) | 97 (38.2%) | NS |
| Aetiology | |||
| Alcoholic liver disease | 27 (71.1%) | 151 (59.4%) | NS |
| Primary biliary cirrhosis | 3 (7.9) | 27 (10.6%) | NS |
| Hepatitis C | 0 | 20 (7.9%) | NS |
| Cryptogenic cirrhosis | 5 (13.2%) | 23 (9.1%) | NS |
| Autoimmune | 1 (2.6%) | 8 (3.1%) | NS |
| Cystic fibrosis | 0 | 6 (2.4%) | NS |
| Primary sclerosing cholangitis | 1 (2.6%) | 7 (2.8%) | NS |
| Hepatitis B | 1 (2.6%) | 3 (1.2%) | NS |
| Other | 0 | 9 (3.5%) | NS |
| PPG (mm Hg) | |||
| Pre-TIPSS | 9.8 (0.4) | 22.1 (0.4) | <0.001 |
| Post-TIPSS | 4.2 (0.5) | 7.6 (0.3) | <0.05 |
| Reduction post-TIPSS | 5.6 (0.5) | 14.6 (0.5) | <0.001 |
| Child-Pugh score | 9.1 (0.5) | 9.9 (0.2) | NS |
| Indication | |||
| Oesophageal variceal bleeding | 20 (52.6%) | 212 (83.5%) | <0.001 |
| Gastric variceal bleeding | 14 (36.8%) | 26 (10.2%) | <0.001 |
| Gastric and oesophageal variceal bleeding | 2 (5.3%) | 10 (3.9%) | NS |
| Ectopic variceal bleeding | 2 (5.3%) | 6 (2.4%) | NS |
Group 1, all patients with PPG ≤12 mm Hg; group 2, all patients with PPG >12 mm Hg.